LAS VEGAS, Jan. 7, 2019 /PRNewswire/ — Omron Healthcare is advancing its mission of Going for Zero™ heart attacks and strokes with breakthrough new heart health technology offerings at the 2019 Consumer Electronics Show (CES). The global market leader of personal heart health and wellness technology is launching its highly-anticipated HeartGuide, the first […]
Rhythm
ARCA biopharma Updates Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial
WESTMINSTER, Colo., Dec. 20, 2018 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced that it has submitted an amendment to its Special Protocol Assessment (SPA)request to the U.S. Food and Drug Administration (FDA). The amendment addresses […]
iRhythm Technologies to Present at the J.P. Morgan 37th Annual Healthcare Conference
SAN FRANCISCO, Dec. 19, 2018 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming J.P. Morgan 37th Annual Healthcare Conference in San Francisco, CA. iRhythm’s management is scheduled to […]
HeartGuide, the highly-anticipated first wearable blood pressure monitor from Omron, available for pre-order on December 20th
LAKE FOREST, Ill., Dec. 20, 2018 /PRNewswire/ — Omron Healthcare, the number one doctor and pharmacist recommended blood pressure monitor brand, will open pre-orders for its new HeartGuide™, the first wearable blood pressure monitor, on December 20th at 12:00pm EST in the United States on OmronHealthcare.com. HeartGuide, an oscillometric blood pressure monitor in the design of a wrist watch, […]
Cardiva Medical Announces FDA Approval of the VASCADE MVP Vascular Closure System for Multi-Site Vessel Closure Following Electrophysiology Procedures
SANTA CLARA, Calif.–(BUSINESS WIRE)–Cardiva Medical, Inc., an innovator in the field of vascular closure, today announced that the company has received PMA approval from the U.S. Food and Drug Administration (FDA) for the VASCADE® MVP Venous Vascular Closure System. VASCADE MVP is the first and only vascular closure system designed […]
Bardy Diagnostics™ Selected As Winner Of The Fierce Innovation Life Sciences Award
SEATTLE, Dec. 17, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today that it has been selected as a winner in the sixth annual Fierce Innovation Awards: Life Sciences Edition, an awards program from the leading industry publisher of FierceBiotech and FiercePharma aimed at identifying and showcasing outstanding innovations driving improvements […]
Cambridge Cardiologist and Cardiology MIT Fellow to Release the ‘Heartsense monitor’, the First AI-Driven Wearable Heart Monitor That Prevents Heart Disease and Stroke
BOSTON, Dec. 13, 2018 /PRNewswire/ — Cambridge Heartwear, a medical provider of low-cost, next-generation wearable heart monitors that uses artificial intelligence (AI) to diagnose heart rhythm and respiratory problems in real time is announcing the launch of their company and release of their Heartsense monitor in 2019. In the U.S., strokes are among […]
Geneva Health Solutions Hits Critical Milestones Driving Growth; Predicts Cardiac Data Explosion in 2019
NEW YORK–(BUSINESS WIRE)–Geneva Health Solutions (GHS), the leading cloud-based technology platform and service for managing data from implantable cardiac devices, announces triple-digit revenue growth in 2018, an indicator of the explosive growth of implantable cardiac device data expected in 2019. This year, GHS has also tripled its client base and workforce, […]
Leviticus Cardio Announces Success of Groundbreaking Six Month Chronic Animal Study
PETAH TIKVA, Israel, Dec. 6, 2018 /PRNewswire/ — Leviticus Cardio, inventors of the versatile transcutaneous Coplanar Energy Transfer (CET) system used with implanted left ventricular assist devices (LVADs), announces the successful completion of a 180-day preclinical chronic animal study to evaluate its CET technology in combination with a commercial heart pump. Leviticus’ CET technology compliments […]
BioSig Technologies To Commence First–in-Human Studies at Mayo Clinic
Santa Monica, CA, Dec. 06, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company has signed an agreement with Mayo Clinic to […]



